Watch for definitive agreement terms on the additional Beta Beteiligungs stake and any further capital raises given the company's cash burn. The activist 13D/A filing from Fung & Tun Ltd adds pressure for strategic changes or governance improvements.
Price Chart
Executive Summary
Masonglory Ltd entered into a securities purchase agreement for a $1.0M private placement of 667,000 Class A ordinary shares at $1.50/share, with attached Series A and B warrants exercisable at $1.30 and $1.10 respectively. Proceeds are earmarked for the continued acquisition of equity interests in Beta Beteiligungs und Besitz GmbH, though no definitive agreement for the additional stake has been reached. The dilutive financing comes amid a deteriorating financial position (FY2026 net loss of $8.0M, gross profit halved) and an activist stake (Fung & Tun Ltd filed a 13D/A in August 2026), signaling ongoing capital needs and governance concerns.
Key Facts
- Private placement of 667,000 Class A ordinary shares at $1.50/share for gross proceeds of $1,000,500.
- Each purchaser receives Series A warrants for 166,750 shares at $1.30 and Series B warrants for 166,750 shares at $1.10, exercisable for two years.
- Proceeds intended to fund additional equity acquisition in Beta Beteiligungs und Besitz GmbH; no definitive agreement yet.
- FY2026 annual report (20-F) showed net loss of $8.0M, gross profit halved to $1.04M, and cash burned to $315K.
- Activist investor Fung & Tun Ltd filed a Schedule 13D/A on August 27, 2026, indicating activist pressure.
- Each purchaser represents it is not affiliated with the company and will hold less than 5% voting power post-closing.
Financial Impact
Dilution of ~667,000 new shares (plus up to 333,500 warrant shares) against a weak cash position of $315K and ongoing losses; gross proceeds of $1.0M are modest relative to the $8.0M net loss.
Risk Factors
- Dilution from 667,000 new shares plus up to 333,500 warrant shares overhangs the stock.
- No definitive agreement for the target acquisition; proceeds may be deployed without clear value creation.
- Weak financials (net loss, halved gross profit, low cash) increase risk of further dilutive financing.
- Activist involvement could lead to board changes or strategic shifts, creating uncertainty.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-103905 |
| Document: ea030687201ex99-1.htm | 0001213900-26-103905 |
| Document: 0001213900-26-103905-index-headers.html | 0001213900-26-103905 |
| Document: 0001213900-26-103905-index.html | 0001213900-26-103905 |
| Document: 0001213900-26-103905.txt | 0001213900-26-103905 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $2.72 $2.73 | ▲ +0.37% | ▲ +0.89% | $3.49 (+28.31%) |
Oct 21, 2026 5d ago | 6-K | $2.38 $2.72 | ▲ +14.29% | ▲ +15.47% | $3.49 (+46.64%) |
Oct 6, 2026 20d ago | 6-K | $5.01 $4.30 | ▲ +14.17% | ▲ +13.93% | $3.49 (+30.34%) |
Sep 28, 2026 28d ago | 6-K | $3.13 $4.44 | ▼ −41.85% | ▼ −42.04% | $3.49 (−11.50%) |
Sep 28, 2026 28d ago | Press Release | $3.13 $4.44 | ▼ −41.85% | ▼ −42.04% | $3.49 (−11.50%) |
Sep 24, 2026 4w ago | 6-K | $1.97 $8.07 | ▼ −309.64% | ▼ −309.10% | $3.49 (−77.16%) |
Aug 25, 2026 8w ago | 6-K | $2.25 $2.06 | ▼ −8.44% | ▼ −8.47% | $3.49 (+55.11%) |
Aug 13, 2026 10w ago | Press Release | $2.85 $2.75 | ▼ −3.51% | ▼ −3.31% | $3.49 (+22.46%) |
Aug 6, 2026 11w ago | 6-K | $0.2801 $0.2697 | ▲ +3.71% | ▲ +4.32% | $3.49 (−1145.98%) |
Aug 6, 2026 11w ago | Press Release | $0.2801 $0.2697 | ▼ −3.71% | ▼ −4.32% | $3.49 (+1145.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers